First Cohort Benefits From Atsena Therapeutics XLRS Gene Therapy
UF startup Atsena Therapeutics has announced positive preliminary data for its gene therapy candidate ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
UF Health Now Using Precision Radiation Procedure for Eye Cancer
For patients with eye cancer, University of Florida Health ophthalmology specialist Gibran S. Khurshid, M.D., is sowing seeds of hope. In Khurshid’s case, those seeds are tiny particles of radioactive iodine.
Therapeutics Company Announces Exclusive Licensing Agreements for Hearing Loss Gene Therapy Technology Developed by UF Researcher
Decibel Therapeutics, a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, has announced exclusive license... Read More
